298 related articles for article (PubMed ID: 16406223)
1. Isoprenoids and Alzheimer's disease: a complex relationship.
Cole SL; Vassar R
Neurobiol Dis; 2006 May; 22(2):209-22. PubMed ID: 16406223
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of statins in Alzheimer's disease.
Kandiah N; Feldman HH
J Neurol Sci; 2009 Aug; 283(1-2):230-4. PubMed ID: 19321181
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
4. Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease.
Siegel GJ; Chauhan NB; Feinstein DL; Li G; Larson EB; Breitner JC; Montine TJ
Neurology; 2008 Jul; 71(5):383; author reply 383. PubMed ID: 18663190
[No Abstract] [Full Text] [Related]
5. Does statin use decrease the amount of Alzheimer disease pathology in the brain?
Silbert LC
Neurology; 2007 Aug; 69(9):E8-11. PubMed ID: 17724280
[No Abstract] [Full Text] [Related]
6. Amyloid inhibitors and Alzheimer's disease.
Xia W
Curr Opin Investig Drugs; 2003 Jan; 4(1):55-9. PubMed ID: 12625030
[TBL] [Abstract][Full Text] [Related]
7. Link between heart disease, cholesterol, and Alzheimer's disease: a review.
Sparks DL; Martin TA; Gross DR; Hunsaker JC
Microsc Res Tech; 2000 Aug; 50(4):287-90. PubMed ID: 10936882
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol and Alzheimer's disease--is there a relation?
Sjögren M; Mielke M; Gustafson D; Zandi P; Skoog I
Mech Ageing Dev; 2006 Feb; 127(2):138-47. PubMed ID: 16332384
[TBL] [Abstract][Full Text] [Related]
9. A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model.
Bharathi ; Shamasundar NM; Sathyanarayana Rao TS; Dhanunjaya Naidu M; Ravid R; Rao KS
Brain Res Rev; 2006 Sep; 52(2):275-92. PubMed ID: 16782202
[TBL] [Abstract][Full Text] [Related]
10. Neuropathology in Alzheimer's disease: target of pharmacotherapy.
Souder E
J Am Acad Nurse Pract; 2005 Mar; Suppl():3-5. PubMed ID: 16033022
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease therapeutics: new approaches to an ageing problem.
Small DH; Losic D; Martin LL; Turner BJ; Friedhuber A; Aguilar MI
IUBMB Life; 2004 Apr; 56(4):203-8. PubMed ID: 15230347
[TBL] [Abstract][Full Text] [Related]
12. Statins, incident Alzheimer disease, change in cognitive function, and neuropathology.
Pappolla MA
Neurology; 2008 Dec; 71(24):2020; author reply 2020-1. PubMed ID: 19086266
[No Abstract] [Full Text] [Related]
13. Cholesterol and statins in Alzheimer's disease: current controversies.
Fonseca AC; Resende R; Oliveira CR; Pereira CM
Exp Neurol; 2010 Jun; 223(2):282-93. PubMed ID: 19782682
[TBL] [Abstract][Full Text] [Related]
14. Methylene blue and Alzheimer's disease.
Oz M; Lorke DE; Petroianu GA
Biochem Pharmacol; 2009 Oct; 78(8):927-32. PubMed ID: 19433072
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
[TBL] [Abstract][Full Text] [Related]
16. A Phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer disease.
Aisen PS; Saumier D; Briand R; Laurin J; Gervais F; Tremblay P; Garceau D
Neurology; 2006 Nov; 67(10):1757-63. PubMed ID: 17082468
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol homeostasis and the pathophysiology of Alzheimer's disease.
Blain JF; Poirier J
Expert Rev Neurother; 2004 Sep; 4(5):823-9. PubMed ID: 15853509
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Abeta production by NF-kappaB inhibitors.
Paris D; Patel N; Quadros A; Linan M; Bakshi P; Ait-Ghezala G; Mullan M
Neurosci Lett; 2007 Mar; 415(1):11-6. PubMed ID: 17223266
[TBL] [Abstract][Full Text] [Related]
19. Plaques, tangles, and memory loss in mouse models of neurodegeneration.
Eriksen JL; Janus CG
Behav Genet; 2007 Jan; 37(1):79-100. PubMed ID: 17072762
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease, cholesterol, and statins: the junctions of important metabolic pathways.
Silva T; Teixeira J; Remião F; Borges F
Angew Chem Int Ed Engl; 2013 Jan; 52(4):1110-21. PubMed ID: 23280829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
